
Chandan Healthcare Limited
Chandan Healthcare Limited(CHANDAN)
Total Shares
67,52,000
Issue Size
₹107.36 Cr
Price Band
₹151 – ₹159
Lot Size
800 shares
Min. Investment
₹1,27,200
Max. Investment
₹1,27,200
Open Date
10 Feb, 2025
Close Date
12 Feb, 2025
Allotment
13 Feb, 2025
Listing
17 Feb, 2025
Max. Investment
₹1,27,200
Announced
10 Feb, 2025
Opening Date
10 Feb, 2025
Closing Date
12 Feb, 2025
Basis of Allotment
13 Feb, 2025
Initiation of Refunds
14 Feb, 2025
Credit of Shares
14 Feb, 2025
Listing Date
17 Feb, 2025
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Chandan Healthcare Limited IPO
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services.
As of August 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 15 cities across Uttar Pradesh and over 10 in Uttarakhand.
As of August 31, 2024, the company offers 1,118 tests across different specialties. The test m
Chandan Healthcare Limited IPO Share Price and Issue Size
Issue Breakdown
Shareholding
Chandan Healthcare Limited IPO Financials Health
Chandan Healthcare Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| HNI Minimum | 2 | 1600 | ₹2,54,400 |
| Retail Minimum | 1 | 800 | ₹1,27,200 |
| Retail Maximum | 1 | 800 | ₹1,27,200 |
(All values in CR)
Chandan Healthcare Limited IPO Valuation
| Metric | Value |
|---|---|
| Debt/Equity | 1.02 |
| PAT Margin | 9.26 |
| ROCE | 35.04% |
| ROE | 47.60% |
| RoNW | 39.61% |
(All values in CR)
Strength & Risk of Chandan Healthcare Limited IPO
1. Strong Geographical presence in Uttarakhand.
2. Integrated diagnostics provider with one-stop solution offering pathology and radiology testing, and medical consultation services.
3. Track record of profitability and consistent financial performance.
4. Dedicated management team with significant industry experience.
1. Any interruptions at our flagship diagnostic centres may affect our ability to process diagnostic tests, which in turn may adversely affect our business, results of operations and financial condition.
2. Our business and prospects may be adversely affected if we are unable to maintain and grow our brand name and brand image.
3. We are dependent on B2C and few other customers for a major part of our revenues. Further we do not enter long-term arrangements with our customers and any failure to continue our existing arrangements could adversely affect our business and results of operations.
4. Any non-renewal or cancellation of our arrangements with our institutional customers, including hospitals, and government agencies may adversely affect our business, results of operations and financial condition.
5. Our operations are only focused on Uttar Pradesh and Uttarakhand, and any loss of business in such region could have an adverse effect on our business, results of operations and financial condition.
6. Our primary source of revenue is from our pathology and radiology services and our business may be adversely affected if these categories do not perform as well as expected.
7. We are dependent on our Group Company for a significant part of our revenues. Further we have not entered into any long-term arrangements with our group company i.e. Chandan Hospital Limited and any failure to deliver the commitment could adversely affect our business and results of operations.
8. We rely on domestic suppliers for the supply of medical consumables particularly suppliers from Uttar Pradesh and any delay, interruption or reduction in such supply could adversely affect our business, results of operations, financial condition and cash flows.
9. Our contingent liabilities as stated in our Restated Financial Statements could affect our financial condition.
10. We depend on third parties to provide us our reagents and films, and any failure to continue to do so or recall of existing testing equipment and reagents could adversely affect our business, results of operations and financial condition.
Chandan Healthcare Limited IPO Subscription Status
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 18,48,800 | 18,48,800 | 29.4 |
| Employees | 0.21 | 2,45,600 | 51,200 | 0.81 |
| HNI | 19.22 | 9,25,600 | 1,77,91,200 | 282.88 |
| Market Maker | 1.00 | 3,39,200 | 3,39,200 | 5.39 |
| QIB | 7.58 | 12,33,600 | 93,56,800 | 148.77 |
| Retail | 2.44 | 21,59,200 | 52,72,800 | 83.84 |
| Total | 7.11 | 45,64,000 | 3,24,72,000 | 516.3 |
Chandan Healthcare Limited IPO GMP
Last updated 05 Feb, 2025 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 05 Feb, 2025 | 159 | ₹0▼ | -- | ₹159 (0.00%) | - | 05 Feb, 2025 |
| 06 Feb, 2025 | 159 | ₹14 | 8500 | ₹173 (8.81%) | - | 06 Feb, 2025 |
| 07 Feb, 2025 | 159 | ₹14▲ | 8500 | ₹173 (8.81%) | - | 07 Feb, 2025 |
| 10 Feb, 2025 | 159 | ₹8 | 4900 | ₹167 (5.03%) | - | 10 Feb, 2025 |
| 11 Feb, 2025 | 159 | ₹8▲ | 4900 | ₹167 (5.03%) | - | 11 Feb, 2025 |
| 12 Feb, 2025 | 159 | ₹3 | 1800 | ₹162 (1.89%) | - | 12 Feb, 2025 |
| 13 Feb, 2025 | 159 | ₹3▲ | 1800 | ₹162 (1.89%) | - | 13 Feb, 2025 |
| 17 Feb, 2025 | 159 | ₹0 | -- | ₹159 (0.00%) | - | 17 Feb, 2025 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Chandan Healthcare Limited IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Chandan Healthcare Limited under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.